Concomitant Cephalosporins or Vancomycin During or After Treatment of Clostridioides difficile Infection Increases Risk of 3-Month CDI Recurrence

被引：0
|
作者：
Damianos, John [1 ]
Chaar, Abdelkader [2 ]
Rizwan, Rabia [2 ]
Mansoor, Muhammad Sohail [3 ]
Sharma, Prabin [4 ]
Malik, Umer Ejaz [5 ]
Alnahhas, Houssam [6 ]
Feuerstadt, Paul [1 ,7 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA
[3] GI Specialists Georgia, Marietta, GA USA
[4] NYU Langone Long Isl, Mineola, NY USA
[5] Albany Med Ctr, Albany, NY USA
[6] Syria Publ Hlth Network, London, England
[7] PACT Gastroenterol Ctr, Hamden, CT USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S207
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 35 条
  • [1] The Risk of Clostridioides difficile Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
    Hall, Ronald G., II
    Cole, Travis J.
    Shaw, Chip
    Alvarez, Carlos A.
    ANTIBIOTICS-BASEL, 2022, 11 (03):
  • [2] SComparing Recurrence Rates of Clostridioides difficile Infection (CDI) for Patients With Inflammatory Bowel Disease After Long vs Short-Term Oral Vancomycin for Initial Episode of CDI
    Berman, Ethan
    Yoon, Bo Hyung
    Javia, Amy
    Kozuch, Patricia
    Choudhary, Cuckoo
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S376 - S376
  • [3] Comparing Recurrence Rates of Clostridioides difficile Infection in Patients With Inflammatory Bowel After Low, Medium, and High Doses of Oral Vancomycin for the Initial Episode of CDI
    Khan, Adnan
    Mitsuhashi, Shuji
    Chauhan, Kashyap
    Dimarino, Michael
    Ross, Heather M.
    Zhang, Peter
    Schafer, Michelle
    Mujumdar, Sahaj
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S760 - S760
  • [4] Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
    Louie, Thomas J.
    Cannon, Kris
    Byrne, Brendan
    Emery, Judy
    Ward, Linda
    Eyben, Melissa
    Krulicki, Walter
    CLINICAL INFECTIOUS DISEASES, 2012, 55 : S132 - S142
  • [5] Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence
    Escudero-Sanchez, Rosa
    Ramos-Martinez, Antonio
    Caballero-Bermejo, Antonio F.
    Diaz-Pollan, Beatriz
    Ruiz-Carrascoso, Guillermo
    Samperio, Maria Olmedo
    Garcia, Patricia Munoz
    Amador, Paloma Merino
    Romo, Fernando Gonzalez
    Segarra, Oriol Martin
    Jimenez, Gema Navarro
    Albendea, Laura del Campo
    Garcia, Alfonso Muriel
    Cobo, Javier
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (03) : 533 - 540
  • [6] Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence
    Rosa Escudero-Sanchez
    Antonio Ramos-Martínez
    Antonio F. Caballero-Bermejo
    Beatriz Díaz-Pollán
    Guillermo Ruiz-Carrascoso
    María Olmedo Samperio
    Patricia Muñoz García
    Paloma Merino Amador
    Fernando González Romo
    Oriol Martín Segarra
    Gema Navarro Jiménez
    Laura del Campo Albendea
    Alfonso Muriel García
    Javier Cobo
    European Journal of Clinical Microbiology & Infectious Diseases, 2024, 43 : 533 - 540
  • [7] ASSOCIATION OF FLUOROQUINOLONESOR CEPHALOSPORINS WITH CLOSTRIDIOIDES DIFFICILE INFECTION AFTER EMPIRIC TREATMENT FOR COMMUNITY-ACQUIRED PNEUMONIA
    Deshpande, Abhishek
    Patel, Preethi
    Yu, Pei-Chun
    Imrey, Peter B.
    Rothberg, Michael B.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S36 - S36
  • [8] Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin
    Merchante, Nicolas
    Herrero, Rocio
    Valverde-Fredet, Maria Dolores
    Rodriguez-Fernandez, Miguel
    Pinargote, Hector
    Martinez-Marcos, Francisco J.
    Gil-Anguita, Concepcion
    Garcia-Lopez, Maria
    Pitarch, Maria Tasias
    De Medrano, Vicente Abril Lopez
    Lorite, Miguel Nicolas Navarrete
    Gomez-Ayerbe, Cristina
    Leon, Eva
    Gonzalez-De La Aleja, Pilar
    Castillo, Ana Ruiz
    Aller, Ana I.
    Rodriguez, Juan Carlos
    Fonseca, Julia Ternero
    Corzo, Juan E.
    Perez, Alberto Naranjo
    Trigo-Rodriguez, Marta
    Merino, Esperanza
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (06):
  • [9] Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin
    Merchante, Nicolas
    Herrero, Rocio
    Valverde-Fredet, Maria Dolores
    Rodriguez-Fernandez, Miguel
    Pinagorte, Hector
    Martinez-Marcos, Francisco J.
    Gil-Anguita, Concepcion
    Garcia-Lopez, Maria
    Pitarch, Maria Tasias
    De Medrano, Vicente Abril Lopez
    Lorite, Miguel Nicolas Navarrete
    Gomez-Ayerbe, Cristina
    Leon, Eva
    Gonazlez-De La Aleja, Pilar
    Castillo, Ana Ruiz
    Aller, Ana, I
    Rodriguez, Juan Carlos
    Fonseca, Julia Ternero
    Corzo, Juan E.
    Perez, Alberto Naranjo
    Trigo-Rodriguez, Marta
    Merino, Esperanza
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (02):
  • [10] First Clostridioides difficile Recurrence Is Highest Following Concomitant Antimicrobial Administration During and Within 30 Days of Treatment
    Chaar, Abdelkader
    Damianos, John
    Rizwan, Rabia
    Al-Nahhas, Houssam
    Mansoor, Muhammad Sohail
    Sharma, Prabin
    Malik, Umer
    Feuerstadt, Paul
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (11) : 4221 - 4229
1234